Ad is loading...
MENU
AUPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aurinia Pharmaceuticals (AUPH) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

AUPH is expected to report earnings to fall 66.70% to 3 cents per share on March 04

Aurinia Pharmaceuticals AUPH Stock Earnings Reports
Q4'24
Est.
$0.03
Q3'24
Beat
by $0.08
Q2'24
Est.
$0.01
Q1'24
Beat
by $0.07
Q4'23
Missed
by $0.03
The last earnings report on November 07 showed earnings per share of 10 cents, beating the estimate of 1 cents. With 1.44M shares outstanding, the current market capitalization sits at 1.16B.
View a ticker or compare two or three
AUPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com